Home › Pulmonary Arterial Hypertension › New York
Pulmonary Arterial Hypertension clinical trials in New York
6 studies for Pulmonary Arterial Hypertension are looking for participants at sites in New York.
Cities in New York
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA013, Rochester
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 16, 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- NYU Langone Health, New York
- Westchester Medical Center, Valhalla
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07365332Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- NYU Langone Health, New York
- University of Rochester Medical Center, Rochester
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06274801Pulmonary Hypertension Association Registry
- Weill Cornell Medical Center, New York
- Columbia University Medical Center/NewYork-Presbyterian Hospital, New York
- University of Rochester Medical Center, Rochester
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Cornell University, New York
- University of Rochester, New York
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2025 · NCT04555161Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Columbia University Medical Center, New York
- Maria Fareri Children's Hospital at WMC Health/Westchester Medical Center, New York
RecruitingObservational study
1 Day – 21 Years · All sexes · Updated Mar 13, 2025 · NCT02249923From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.